| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
Papers In Press, published online ahead of print November 16, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medicine Dept., University of California San Diego, La Jolla, CA 92093-0682
Corresponding Author: dsteinberg{at}ucsd.edu
The first in this series of historical reviews dealt with the pioneering animal model work of Anitschkow, implicating blood cholesterol in the pathogenesis of atherosclerosis, and the pivotally important work of Gofman, providing evidence that blood cholesterol was also a major factor in the human disease. This second installment reviews the early lines of evidence linking hypercholesterolemia in humans to the progression of atherosclerosis and the risk of coronary heart disease. The case is made that by 1972 the evidence was already strong enough to justify intervention to lower blood cholesterol levels if all the available lines of evidence had been taken into account. Yet it would be almost two decades before lowering blood cholesterol levels became a national public health goal. Some of the reasons the “cholesterol controversy’ continued in the face of powerful evidence supporting it are discussed.
Revised on November 16, 2004
Accepted on November 1, 2004
Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy, part II: The early evidence linking hypercholesterolemia to coronary disease in humans
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  R. R. S. Packard and P. Libby Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction Clin. Chem., January 1, 2008; 54(1): 24 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. F. Tacer, D. Kuzman, M. Seliskar, D. Pompon, and D. Rozman TNF-{alpha} interferes with lipid homeostasis and activates acute and proatherogenic processes Physiol Genomics, October 19, 2007; 31(2): 216 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Natella, M. Nardini, F. Belelli, and C. Scaccini Coffee drinking induces incorporation of phenolic acids into LDL and increases the resistance of LDL to ex vivo oxidation in humans Am. J. Clinical Nutrition, September 1, 2007; 86(3): 604 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Steinberg Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy, part V: The discovery of the statins and the end of the controversy J. Lipid Res., July 1, 2006; 47(7): 1339 - 1351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Freedland, G. E. Miller, and D. S. Sheps THE GREAT DEBATE EDITORIAL, REVISITED: RESPONSE Psychosom Med, July 1, 2006; 68(4): 638 - 640. [Full Text] [PDF]
|
|
|
|
|
|
D. Steinberg Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy, part IV: The 1984 Coronary Primary Prevention Trial ends it--almost J. Lipid Res., January 1, 2006; 47(1): 1 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Gotto Jr Evolving Concepts of Dyslipidemia, Atherosclerosis, and Cardiovascular Disease: The Louis F. Bishop Lecture J. Am. Coll. Cardiol., October 4, 2005; 46(7): 1219 - 1224. [Full Text] [PDF]
|
|
|
|
|
|
D. Steinberg Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy, part III: mechanistically defining the role of hyperlipidemia J. Lipid Res., October 1, 2005; 46(10): 2037 - 2051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-M. Li, B. H. Chung, J. B. Presley, G. Malek, X. Zhang, N. Dashti, L. Li, J. Chen, K. Bradley, H. S. Kruth, et al. Lipoprotein-like Particles and Cholesteryl Esters in Human Bruch's Membrane: Initial Characterization Invest. Ophthalmol. Vis. Sci., July 1, 2005; 46(7): 2576 - 2586. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |
